Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

pSivida drug target gets FDA priority review

August 31, 2010 2:36 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

The U.S. Food and Drug Administration has granted priority review status for the New Drug Application of Iluvien, the lead product of Watertown-based biotechnology company pSivida Corp. and intended to treat diabetic macular edema.

Reportlinker Adds Urological Disorders Therapeutics to 2016 - Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Ma...

August 31, 2010 2:35 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 31 /- Reportlinker.com announces that a new market research report is available in its catalogue: Urological Disorders Therapeutics to 2016 - Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Markets...

TOPICS:

Reportlinker Adds All Change in the Coronary Stent Market

August 31, 2010 2:35 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 31 /- Reportlinker.com announces that a new market research report is available in its catalogue: All Change in the Coronary Stent Market http://www.reportlinker.com/p0203108/All-Change-in-the-Coronary-Stent-Market.html Use this report to… Review the prospects for key...

TOPICS:
Advertisement

Reportlinker Adds The Global Orthobiologics Market - Players, products and technologies driving change 2008

August 31, 2010 2:35 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 31 /- Reportlinker.com announces that a new market research report is available in its catalogue: The Global Orthobiologics Market - Players, products and technologies driving change 2008...

TOPICS:

Preventive cancer surgeries save women's lives

August 31, 2010 2:34 pm | by EurekAlert | News | Comments

(Northwestern University) A new study underscores the importance for women with a family history of breast or ovarian cancer to get genetic testing for the BRCA1 and BRCA2 genes that make them more likely to develop lethal breast or ovarian cancer, says a Northwestern Medicine oncologist....

TOPICS:

Increasing Selenium Intake May Decrease Bladder Cancer Risk

August 31, 2010 2:33 pm | by AACR | News | Comments

According to results of a study published in the September issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, selenium intake is associated with decreased risk of bladder cancer.

TOPICS:

Reportlinker Adds Diagnostic Imaging Market to 2016 - Nuclear Imaging Systems and Ultrasound Systems to be the Key Revenue Generators

August 31, 2010 2:33 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 31 /- Reportlinker.com announces that a new market research report is available in its catalogue: Diagnostic Imaging Market to 2016 - Nuclear Imaging Systems and Ultrasound Systems to be the Key Revenue Generators...

TOPICS:

Tenet completes tender offer for senior notes

August 31, 2010 1:45 pm | by The Associated Press | News | Comments

Tenet Healthcare Corp. said Tuesday it completed a tender offer to buy a portion of its outstanding 7.375 percent senior notes due 2013.The hospital operator said it received tenders from the holders of about 78 percent or about $781.5 million of the notes before the offer's early expiration...

Advertisement

Galahad Metals Announces a Change in Its Board of Directors

August 31, 2010 12:45 pm | by The Associated Press | News | Comments

http://www.phoenixmatachewan.com/index.php () —Galahad Metals Inc. (TSX VENTURE: GAX) ("the Company") announced today that it is pleased to appoint a new director, Mr. Michael Newman. The new director will be joining remaining directors Mr. Robin Dow, Mr. Robert Schellenberg and Mr. Kevin...

Stromedix lung disease drug gets boost from FDA

August 31, 2010 10:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Stromedix Inc. has received word from the U.S. Food and Drug Administration that its potential drug to treat a fatal lung disease will receive orphan drug status, intended to accelerate development of treatments for rare diseases.

Educational Initiative to Introduce Students to Motorsports Manufacturing

August 31, 2010 10:34 am | by Society of Manufacturing Engineers | News | Comments

Dearborn, Mich. August 31, 2010 — The Illinois Motorsports Institute (IMI) plans on changing the face of manufacturing one student, one turn of the wrench and one valuable connection at a time. More

Reportlinker Adds Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

August 31, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 31 /PRNewswire/ Reportlinker.com announces that a new market research report is available in its catalogue: Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016...

TOPICS:

New ProLogis Report Concludes US and Canadian Industrial Property Markets are On the Mend

August 31, 2010 9:32 am | by Material Handling Industry of America | News | Comments

ProLogis recently announced the release of a new research report on the state of the industrial property markets in the United States and Canada, titled "On the Mend."The report is based on market statistics compiled from a variety of sources,

Ovatech closes successful birth control trial

August 31, 2010 8:39 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Ovatech Inc., a women's health tech startup in Auburndale, has completed a Phase 2 clinical trial of its non-hormonal, intravaginal contraceptive ring, called Ovaprene.

Magic-Seal Packaging Products to Introduce First Vytex® Natural Rubber Latex Napkin Rings

August 31, 2010 8:38 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Aug. 31 /- Vystar® Corporation (OTC Bulletin Board: VYST ), the exclusive creator of Vytex® Natural Rubber Latex (NRL), a multi-patented, all-natural raw material that contains significantly reduced levels of the antigenic proteins found in natural rubber latex (NRL),...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading